These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3546237

  • 1. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M, Masuda T, Mizutani S, Osono M, Kumagai H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [Abstract] [Full Text] [Related]

  • 2. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H, Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T.
    Cancer Res; 1987 Jun 15; 47(12):3062-5. PubMed ID: 3495325
    [Abstract] [Full Text] [Related]

  • 3. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD, Brockman RW, Trader MW, Laster WR, Griswold DP.
    Invest New Drugs; 1987 Dec 15; 5(4):345-51. PubMed ID: 3436739
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R, Takei Y, Yoshida M, Tomiyoshi T, Saino T, Nishikawa K, Nemoto K, Takahashi K, Fujii A, Nakamura T.
    J Antibiot (Tokyo); 1988 Nov 15; 41(11):1629-43. PubMed ID: 3242505
    [Abstract] [Full Text] [Related]

  • 5. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H, Takada T, Nemoto K, Abe F, Fujii A, Takeuchi T.
    J Antibiot (Tokyo); 1989 May 15; 42(5):788-94. PubMed ID: 2524464
    [Abstract] [Full Text] [Related]

  • 6. [Spergualin, a new antitumor antibiotic].
    Takeuchi T.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [Abstract] [Full Text] [Related]

  • 7. Spergualin: a new antitumour antibiotic.
    Umezawa K, Takeuchi T.
    Biomed Pharmacother; 1987 Mar 15; 41(5):227-32. PubMed ID: 3499181
    [Abstract] [Full Text] [Related]

  • 8. [Immunomodulation by antitumor antibiotics].
    Ishizuka M.
    Gan To Kagaku Ryoho; 1986 Mar 15; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Oct 15; 39(10):1461-6. PubMed ID: 3781914
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
    Iwasawa H, Kondo S, Ikeda D, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1982 Dec 15; 35(12):1665-9. PubMed ID: 6926749
    [Abstract] [Full Text] [Related]

  • 11. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
    Takeuchi T, Iinuma H, Kunimoto S, Masuda T, Ishizuka M, Takeuchi M, Hamada M, Naganawa H, Kondo S, Umezawa H.
    J Antibiot (Tokyo); 1981 Dec 15; 34(12):1619-21. PubMed ID: 7333976
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K, Shibasaki C, Hiratsuka M, Arakawa M, Takahashi K, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct 15; 44(10):1101-9. PubMed ID: 1955393
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antitumor activity of spergualin analogues. III. Novel method for synthesis of optically active 15-deoxyspergualin and 15-deoxy-11-O-methylspergualin.
    Umeda Y, Moriguchi M, Ikai K, Kuroda H, Nakamura T, Fujii A, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1987 Sep 15; 40(9):1316-24. PubMed ID: 3680041
    [Abstract] [Full Text] [Related]

  • 14. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells.
    Kerr PG, Atkins RC.
    Immunol Cell Biol; 1991 Jun 15; 69 ( Pt 3)():177-83. PubMed ID: 1835710
    [Abstract] [Full Text] [Related]

  • 15. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun 15; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 16. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM, Kawashima K, Nakashima I, Nagase F.
    Cancer Res; 1988 Nov 15; 48(22):6450-4. PubMed ID: 3263189
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive activity of 15-deoxyspergualin and its effect on skin allografts in rats.
    Masuda T, Mizutani S, Iijima M, Odai H, Suda H, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1987 Nov 15; 40(11):1612-8. PubMed ID: 3693129
    [Abstract] [Full Text] [Related]

  • 18. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A, Arakawa H, Yoshinari T, Naito K, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Apr 15; 39(4):575-80. PubMed ID: 3458691
    [Abstract] [Full Text] [Related]

  • 19. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL, Prakash NJ, Edwards ML, Sjoerdsma A.
    Cancer Res; 1991 Jan 01; 51(1):62-6. PubMed ID: 1988107
    [Abstract] [Full Text] [Related]

  • 20. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr 01; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.